# Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?

> **NCT05075031** · — · UNKNOWN · sponsor: **Kafrelsheikh University** · enrollment: 1500 (estimated)

## Conditions studied

- COVID19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05075031
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2022-01
- **Final completion:** 2022-02
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2021-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05075031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05075031, "Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05075031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*